Dulcy Wolverton to Humans
This is a "connection" page, showing publications Dulcy Wolverton has written about Humans.
Connection Strength
0.085
-
Information transparency with immediate release: Oncology clinician and patient perceptions. Am J Surg. 2024 Jan; 227:165-174.
Score: 0.007
-
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023. J Natl Compr Canc Netw. 2023 09; 21(9):900-909.
Score: 0.007
-
Patient comprehension of breast pathology report terminology: The need for patient-centered resources. Surgery. 2022 09; 172(3):831-837.
Score: 0.007
-
Patient and clinician perceptions of the immediate release of electronic health information. Am J Surg. 2022 07; 224(1 Pt A):27-34.
Score: 0.007
-
Breast MRI during Neoadjuvant Chemotherapy: Lack of Background Parenchymal Enhancement Suppression and Inferior Treatment Response. Radiology. 2021 11; 301(2):295-308.
Score: 0.006
-
The Waiting Game: How Long Are Breast Cancer Patients Waiting for Definitive Diagnosis? Ann Surg Oncol. 2020 Oct; 27(10):3641-3649.
Score: 0.006
-
TCIApathfinder: An R Client for the Cancer Imaging Archive REST API. Cancer Res. 2018 08 01; 78(15):4424-4426.
Score: 0.005
-
Don't Be Fooled by DCIS. Oncology (Williston Park). 2017 07 15; 31(7):549-51, 560-1.
Score: 0.005
-
Computer-aided methods help cancer diagnoses. Diagn Imaging (San Franc). 1996 Nov; Suppl Digital X:D17-20.
Score: 0.005
-
Clinical outcome of doubtful mammographic findings. AJR Am J Roentgenol. 1996 Oct; 167(4):1041-5.
Score: 0.005
-
Outcome of long term active surveillance for estrogen receptor-positive ductal carcinoma in situ. Breast. 2011 Dec; 20(6):529-33.
Score: 0.003
-
Magnetic resonance imaging captures the biology of ductal carcinoma in situ. J Clin Oncol. 2006 Oct 01; 24(28):4603-10.
Score: 0.002
-
Fibroepithelial lesions with cellular stroma on breast core needle biopsy: are there predictors of outcome on surgical excision? Am J Clin Pathol. 2005 Sep; 124(3):342-54.
Score: 0.002
-
Combined diffuse optical spectroscopy and contrast-enhanced magnetic resonance imaging for monitoring breast cancer neoadjuvant chemotherapy: a case study. J Biomed Opt. 2005 Sep-Oct; 10(5):051503.
Score: 0.002
-
Computerized analysis of digitized mammograms of BRCA1 and BRCA2 gene mutation carriers. Radiology. 2002 Nov; 225(2):519-26.
Score: 0.002
-
Performance parameters for screening and diagnostic mammography: specialist and general radiologists. Radiology. 2002 Sep; 224(3):861-9.
Score: 0.002
-
Magnetic resonance imaging for primary breast cancer management: current role and new applications. Endocr Relat Cancer. 2002 Jun; 9(2):141-53.
Score: 0.002
-
Computerized classification of benign and malignant masses on digitized mammograms: a study of robustness. Acad Radiol. 2000 Dec; 7(12):1077-84.
Score: 0.002
-
Integration of breast imaging into cancer management. Curr Oncol Rep. 2000 Nov; 2(6):572-81.
Score: 0.002
-
Computerized analysis of mammographic parenchymal patterns for breast cancer risk assessment: feature selection. Med Phys. 2000 Jan; 27(1):4-12.
Score: 0.001
-
Computerized analysis of lesions in US images of the breast. Acad Radiol. 1999 Nov; 6(11):665-74.
Score: 0.001
-
Automated computerized classification of malignant and benign masses on digitized mammograms. Acad Radiol. 1998 Mar; 5(3):155-68.
Score: 0.001
-
Malignant and benign clustered microcalcifications: automated feature analysis and classification. Radiology. 1996 Mar; 198(3):671-8.
Score: 0.001
-
Analysis of spiculation in the computerized classification of mammographic masses. Med Phys. 1995 Oct; 22(10):1569-79.
Score: 0.001
-
Automated segmentation of digitized mammograms. Acad Radiol. 1995 Jan; 2(1):1-9.
Score: 0.001